HOME › DRUGS › ELINZANETANT
ACTIVE SUBSTANCE / INN

ELINZANETANT

Brand name(s): Lynkuet, LYNKUET
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA219469
Hot Flashes;Menopause;Breast Neoplasms
ACTIVE SUBSTANCE
Elinzanetant
REGULATORS
FDA · EMA
SPONSORS / MAH
Bayer AG, BAYER HLTHCARE
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LYNKUETNDA219469BAYER HLTHCAREPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LynkuetBayer AGAuthorised17/11/2025Hot Flashes;Menopause;Breast Neoplasms

FULL INTELLIGENCE ON ELINZANETANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →